SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-16-089697
Filing Date
2016-03-23
Accepted
2016-03-23 09:12:35
Documents
86
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 10-K v434647_10k.htm 10-K 775957
2 EXHIBIT 21.1 v434647_ex21-1.htm EX-21.1 3966
3 EXHIBIT 23.1 v434647_ex23-1.htm EX-23.1 3494
4 EXHIBIT 31.1 v434647_ex31-1.htm EX-31.1 7228
5 EXHIBIT 31.2 v434647_ex31-2.htm EX-31.2 7179
6 EXHIBIT 32 v434647_ex32.htm EX-32 3930
7 GRAPHIC tpg6.jpg GRAPHIC 101654
8 GRAPHIC tpg8.jpg GRAPHIC 74319
9 GRAPHIC image_001.jpg GRAPHIC 17809
  Complete submission text file 0001144204-16-089697.txt   6185921

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT aktx-20151231.xml EX-101.INS 1310984
11 XBRL TAXONOMY EXTENSION SCHEMA aktx-20151231.xsd EX-101.SCH 52460
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aktx-20151231_cal.xml EX-101.CAL 49555
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aktx-20151231_def.xml EX-101.DEF 369118
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE aktx-20151231_lab.xml EX-101.LAB 387916
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aktx-20151231_pre.xml EX-101.PRE 426129
Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018
Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702
Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: 10-K | Act: 34 | File No.: 001-36288 | Film No.: 161522700
SIC: 2834 Pharmaceutical Preparations